Compugen
Price & Volume
Stats
See more52W Range | $1.13-$2.38 |
Market Cap | $158.1M |
Shares Short | 979,325 |
Financials
See moreRevenue (12 Mos) | $6.9M |
Revenue Growth (YoY) | -89% |
Gross Profit (12 Mos) | $513,000 |
Diluted EPS | -$0.30 |
News
See moreYahoo Finance • 2 months ago
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million
Yahoo Finance • 3 months ago
Compugen Ltd (CGEN) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
Yahoo Finance • 4 months ago
DATROWAY® Plus Rilvegostomig Showed Promising Tumor Responses in Patients with Metastatic Urothelial Cancer in TROPION-PanTumor03 Phase 2 Trial
Yahoo Finance • 6 months ago
Compugen Ltd (NASDAQ:CGEN) Reports Q2 2025 Revenue and EPS Miss, Shares Drop in Premarket
About
CEO | Dr. Eran Ophir Ph.D. |
Address | Azrieli Center, Holon, Israel, 5885849 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 74 |
